688180.SH
君实生物-U
SSE · Healthcare · Biotechnology · CN
CNY 34.85
−6.87%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 909.73x
- P/E 2028E
- 91.23x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- -40.88x
- PEG TTM
- —
- Price / book
- 6.07x
- Price / sales
- 12.62x
- Price / cash flow
- -78.61x
Enterprise value
- Enterprise value
- CNY 35.0B
- EV / sales
- 12.86x
- EV / EBITDA
- -48.97x
- EV / EBIT
- -46.93x
- Market cap
- CNY 35.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026